Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1495 (LINC01495) is a human gene transcribing a long non-coding RNA that does not overlap any protein-coding genes. As a member of the lincRNA subclass, it is greater than 200 nucleotides in length, and its molecules are involved generally in regulatory functions at the chromatin and transcriptional level, but no specific biological functions, disease associations, or therapeutic uses have yet been established for LINC01495. This gene is catalogued using standard nomenclature for long intergenic non-coding RNAs, and current knowledge is mainly derived from gene family characteristics rather than LINC01495-specific experimental data.
None identified. There are currently no drugs known to target LINC01495, so no mechanisms of action have been described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1495 (LINC01495).